±¹¸³¾Ï¼¾ÅÍ, ´ëÇѾÏÇÐȸ 5°³ Çмú»ó µ¿½Ã ¼ö»ó
2018³â 06¿ù 25ÀÏ 17½Ã 42ºÐ ÀÔ·Â

[¿Óóµ¥Àϸ®]±¹¸³¾Ï¼¾ÅÍ(¿øÀå ÀÌÀº¼÷)´Â Áö³­ 6¿ù 22ÀÏ(±Ý) ¼­¿ï·Ôµ¥È£ÅÚ¿¡¼­ °³ÃÖµÈ ¡®Á¦44Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× ±¹Á¦¾ÏÄÁÆÛ·±½º¡¯¿¡¼­ ÃÑ 5°³ÀÇ Çмú»óÀ» µ¿½Ã ¼ö»óÇß´Ù.

 

ÀÌÀº¼÷ ¿øÀå ¹× °ø¼±¿µ ´ë¿ÜÇù·Â½ÇÀå/Áø´Ü°Ë»çÀÇÇаúÀåÀº ¡®Clinically Significant Unclassified Variants in BRCA1 and BRCA2 Genes among Korean Breast Cancer Patients¡¯·Î, ¿ø¿µÁÖ Á߾Ӿϵî·Ï»ç¾÷ºÎÀåÀº ¡®Lung Cancer Epidemiology in Korea¡¯·Î, ¹ÚÀÎÇý ¾ÏÁß°³¿¬±¸°úÀåÀº ¡®An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer¡¯ ³í¹®À¸·Î °¢°¢ ·Î½´ ¾ÏÇмú»óÀ» ¼ö»óÇß´Ù.


¶ÇÇÑ, Ãֱͼ± ±¹Á¦¾Ï´ëÇпø´ëÇб³ ±³¼ö´Â ¡®Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality¡¯·Î, ÀÌÀº°æ °©»ó¼±¾Ï¼¾ÅÍ Àü¹®ÀÇ´Â ¡®Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer¡¯·Î °¢°¢ ±¤µ¿ ¾ÏÇмú»óÀ» ¼ö»óÇß´Ù.


´ëÇѾÏÇÐȸÁö´Â 1973³â ´ëÇѾϿ¬±¸È¸ ÀâÁö¸¦ ½ÃÀÛÀ¸·Î Áö¼ÓÀûÀ¸·Î ¹ß°£µÇ¾î ÇöÀç SCIE¿¡ µîÀçµÇ´Â ±¹Á¦ÀûÀÎ ¿µ¹®ÇмúÁöÀÎ ¡®Cancer Research and Treatment¡¯·Î ¹ß°£µÇ°í ÀÖ´Ù. ´ëÇѾÏÇÐȸ´Â Çмú´ëȸ ±â°£¿¡ Áö³­ 1³â µ¿¾È ´ëÇѾÏÇÐȸÁö¿¡ ¹ßÇ¥µÈ ³í¹® Áß ¿ì¼ö ³í¹®À» ¼±Á¤ÇØ »óÀ» ¼ö¿©Çϰí ÀÖ´Ù..